Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tower Holdings Inc.

Division of Amneal Pharmaceuticals LLC

Latest From Tower Holdings Inc.

Deals In Depth: October 2014

BMS teamed up with F-start Alpha and also received an option to acquire; BD bought hospital care systems provider CareFusion for $11.8 billion. IPOs made up nearly a quarter of total dollars in both biopharma and device financing.

BioPharmaceutical Medical Device

Impax CEO’s Strategy: Aggressive BD, Restructure R&D And Cut Costs

Since Impax Laboratories’ CEO Wilkinson took the helm in April, the company has completed several significant deals and most recently restructured R&D to deliver savings, but a successful turnaround will require resolving outstanding manufacturing issues.

BioPharmaceutical Business Strategies

Deals Shaping The Medical Industry, November 2014

BioPharmaceutical Medical Device

Impax Buyouts Add Plant, Portfolio And Pipeline

By acquiring three interrelated, privately held companies, Impax adds several branded and generic products, a substantial generic pipeline and an FDA-licensed manufacturing site in New Jersey.

BioPharmaceutical United States
See All

Company Information

UsernamePublicRestriction

Register